ArticleCancer research and treatment2026

Preferential Sensitivity of the EGFR L858M/L861R Mutation to Second-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Chaelin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.